https://www.selleckchem.com/products/bp-1-102.html
59 ABSU, the IMA has 96% sensitivity and 52% specificity for diagnosing epilepsy. IMA may be used as a biomarker for early diagnosis of epilepsy as well as to differentiate epileptic seizure from various non epileptic disorders in the adolescent population. IMA may be used as a biomarker for early diagnosis of epilepsy as well as to differentiate epileptic seizure from various non epileptic disorders in the adolescent population. Defects in the IGF-1 receptor gene ( ) induce IGF-1 resistance, characterized by intrauterine and postnatal